Federal contract award

75A50123F33007

CLINICAL TRIAL PLANNING AND EXECUTION (CTPE)

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeBARDA - ASPR / DAAPPO / BARDA DCMA
NAICS541714 — Research and Development in Biotechnology (except Nanobiotechnology)
PSCAN11 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH
Parent award / vehicle75A50120D00017
Set-asideNot reported
Pricing typeCOST PLUS FIXED FEE
Obligations$34.1M
Current contract value$34.1M
Potential contract value / ceiling$34.5M
Start dateSep 27, 2023
Current end dateJul 31, 2026
Potential end dateJul 31, 2026
Latest award activityJul 13, 2026
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 14 of 14 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Jul 13, 2026P00013$0EO 14398. CLINICAL TRIAL PLANNING AND EXECUTION (CTPE) H5 FLU
Apr 20, 2026P00012$0CLINICAL TRIAL PLANNING AND EXECUTION (CTPE) H5 FLU
Mar 10, 2026P00011$0CLINICAL TRIAL PLANNING AND EXECUTION (CTPE) H5 FLU
Sep 11, 2025P00010$419.6KCLINICAL TRIAL PLANNING AND EXECUTION (CTPE) H5 FLU
Jul 16, 2025P00009$0CLINICAL TRIAL PLANNING AND EXECUTION (CTPE) H5 FLU
Jun 18, 2025P00008$0CLINICAL TRIAL PLANNING AND EXECUTION (CTPE) H5 FLU
Apr 3, 2025P00007$0CLINICAL TRIAL PLANNING AND EXECUTION (CTPE) H5 FLU
Sep 17, 2024P00006$432.4KCLINICAL TRIAL PLANNING AND EXECUTION (CTPE)
Jun 27, 2024P00005$2.9MCLINICAL TRIAL PLANNING AND EXECUTION (CTPE)
May 17, 2024P00004$0CLINICAL TRIAL PLANNING AND EXECUTION (CTPE)
May 6, 2024P00003$0CLINICAL TRIAL PLANNING AND EXECUTION (CTPE)
Apr 17, 2024P00002$0CLINICAL TRIAL PLANNING AND EXECUTION (CTPE)
Oct 27, 2023P00001$0CLINICAL TRIAL PLANNING AND EXECUTION (CTPE)
Sep 27, 20230$30.3MCLINICAL TRIAL PLANNING AND EXECUTION (CTPE)

Research next steps

  1. Confirm the ordering vehicle and your eligibility or a qualified teaming route.
  2. Review the award scope and buyer evidence before making a bid/no-bid decision.